After decades of continuous rises, hospitalisation due to incident ischaemic heart disease has been cut by half, an achievement associated with the decline in smoking and the increase in vascular risk drug therapy.
The results show that, after decades of continuous rises, hospitalisation due to incident IHD in the Spanish adult population fell after 1997, a drop that was associated with the decline in smoking and, in equal measure, with the increase in pharmacological treatment of vascular risk.
Furthermore, we examined revascularisation during the first treatment period, i.e. during the first continuous chain of hospitalisations without discharge home.
The odds of dying from EVD were estimated through binomial regression with age group and year of outbreak as factorial covariates and the number of months since the start of the outbreak and the delay from symptom onset to hospitalisation as continuous covariates.
In conclusion, after decades of continuous rises, incidence of IHD hospitalisation fell from 1997 onwards, a decline that was associated with the decrease in smoking and, in equal measure, with the increase in vascular risk drug therapy.
Other variables achieving statistical significance, but showing lower areas under the ROC curve, included systolic blood pressure, axillary temperature, HIV status, abnormal BCS (yes vs no), duration of illness prior to admission >7 days and time since last hospitalisation (analysed as continuous variable and ordered as <7 days, 7 to 30 days, 30 days to 1 year, >1 year, and never).
Recent reports do indicate a continuous impact of PCV7 on hospitalisations for vaccine serotype CAP.
Furthermore, linear regression analyses were used to determine the association between log-transformed FGF23 as a continuous variable and different metric variables during hospitalisation (duration of surgery and cardiopulmonary bypass, time of hypothermic circulatory arrest, ventilation time, length of stay on the intensive care unit (ICU), and length of in-hospital stay).
Clinical outcomes are collected during our continuous follow-up and include respiratory and non-respiratory death, hospitalisations due to exacerbations of COPD as well as moderate to severe COPD exacerbations treated with systemic corticosteroids and/or antibiotics.
We used Fisher's exact test to assess associations between categorical variables, student's t-test for two normally-distributed continuous variables, log rank test to compare the durations of treatment and hospitalisation between compliant and non compliant, and between survivors and non survivors and t-test for two-sample mean-comparison of paired data for the patients weight evolution.
